COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

HEMOPHILIA SERVICES CONSORTIUM INC
NEW YORK, NY · EIN 133875950 · Form 990 · FY2024 · NTEE E21Z · Health Care · Large ($10M-$50M)
revenue
$20.0M
expenses
$20.0M
net assets
$124K
employees
0
program ratio
99%
mission · from form 990

TO ENHANCE AFFORDABLE CARE TO PEOPLE WITH BLEEDING DISORDERS BY SUPPLYING BLOOD-CLOTTING CONCENTRATES & OTHER MEDICATIONS FOR THE TREATMENT OF HEMOPHILIA & OTHER BLOOD-CLOTTING DISORDERS.

profile · synthesized from sources

Nonprofit organization based in New York that provides blood-clotting concentrates and other medications to improve access to treatment for people with hemophilia and related bleeding disorders. Focuses on enhancing affordable care through direct supply of critical medical products. Operates within the health care sector with a national service scope.

named programs · 1 · from sources

What they call their work

Medication Access Program
Supplies blood-clotting concentrates and other essential medications to individuals with hemophilia and rare bleeding disorders to ensure timely and affordable treatment
activities · 1 group

What they do

  • Bleeding and Blood Disorder Support Services 1 activity
    • Provision of blood-clotting concentrates and medications for bleeding disorders
      Supplies blood-clotting concentrates and other medications for the treatment of hemophilia and other blood-clotting disorders to enhance affordable care for people with bleeding disorders.
financials · form 990 · fy2024
revenue
Total revenue$20.01M
Contributions & grants$00%
Program service revenue$19.65M98%
Investment income$83K0%
Other revenue$271K
expenses
Total expenses$20.01M
Program expenses99%
Admin / overhead1%
Fundraising0%
Salaries & benefits$0
Grants paid out$0
Largest expense lineOther
balance sheet
Total assets$6.90M
Cash$2.48M
Investments$0
Liabilities$6.78M
Net assets$124K
Liquid reserves1.5 mo
6 years on record · 2019–2024 · YoY revenue -5.6%
leadership · form 990 part vii · fy2024

Who runs it

board members · 15
  • Catherine McGuinn — Director
  • Christopher Fieger — Director
  • Christopher Walsh — Director
  • Colin Lahiff — Director/ VP
  • Edward Rogoff — Director
  • Helen Irving — Director
  • Kevin Curtin — Director / VP
  • Linda Mugford — Director / Secretary
  • Mariam Voutsis — Director / President
  • Mark Kovarik — Director
  • Matthew Sclafani — Director
  • Michael Pastier — Director
  • RICHARD EINWECHTER — DIRECTOR/ TREASURER
  • Stephanie Meier — Director
  • Suchitra Acharya — Director
strategies · 1

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Direct Medical Supply Distribution
    methodology: direct_medical_supply_distribution
    By directly supplying blood-clotting concentrates and medications, the organization enables access to affordable treatment for people with hemophilia and other bleeding disorders, because it removes cost and logistical barriers to critical therapies.